Selected research
Industry Growth & Trends
Global Colchicine Industry Growth and Trends Forecast to 2032
Market perspective
The global Colchicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Colchicine include Yunnan Plant Medicine, Xishuangbanna Pharmaceutical, Takeda Pharmaceuticals, Tonghua Limin, Kunming Pharmaceutical, Beijing Jialin Pharmaceutical, Yunnan Shan State, Wockhardt and West-Ward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Colchicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Colchicine market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Colchicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Colchicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Colchicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Colchicine Market by Company
Yunnan Plant Medicine
Xishuangbanna Pharmaceutical
Takeda Pharmaceuticals
Tonghua Limin
Kunming Pharmaceutical
Beijing Jialin Pharmaceutical
Yunnan Shan State
Wockhardt
West-Ward
Rhea Pharmaceutical
Prasco
Odan Laboratories
Medinova
Hikma
Guangdong Pedi
Excellium Pharmaceutical
Cipla
Colchicine Segment by Type
Tablet
Oral Solution
Colchicine Segment by Application
Acute Gout
Chronic Gout
Other Conditions
Colchicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colchicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colchicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colchicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colchicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Colchicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Solution
Applications
- Acute Gout
- Chronic Gout
- Other Conditions
Companies covered
- Yunnan Plant Medicine
- Xishuangbanna Pharmaceutical
- Takeda Pharmaceuticals
- Tonghua Limin
- Kunming Pharmaceutical
- Beijing Jialin Pharmaceutical
- Yunnan Shan State
- Wockhardt
- West-Ward
- Rhea Pharmaceutical
- Prasco
- Odan Laboratories
- Medinova
- Hikma
- Guangdong Pedi
- Excellium Pharmaceutical
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Colchicine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Colchicine Sales Estimates and Forecasts (2021-2032)
- 1.3 Colchicine Market by Type
- 1.3.1 Tablet
- 1.3.2 Oral Solution
- 1.4 Global Colchicine Market Size by Type
- 1.4.1 Global Colchicine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Colchicine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Colchicine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Colchicine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Colchicine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Colchicine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Colchicine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Colchicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Colchicine Industry Trends
- 2.2 Colchicine Industry Drivers
- 2.3 Colchicine Industry Opportunities and Challenges
- 2.4 Colchicine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Colchicine Revenue (2021-2026)
- 3.2 Global Top Players by Colchicine Sales (2021-2026)
- 3.3 Global Top Players by Colchicine Price (2021-2026)
- 3.4 Global Colchicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Colchicine Major Company Production Sites & Headquarters
- 3.6 Global Colchicine Company, Product Type & Application
- 3.7 Global Colchicine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Colchicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Colchicine Players Market Share by Revenue in 2025
- 3.8.3 2025 Colchicine Tier 1, Tier 2, and Tier 3
4 Colchicine Regional Status and Outlook
- 4.1 Global Colchicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Colchicine Historic Market Size by Region
- 4.2.1 Global Colchicine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Colchicine Sales in Value by Region (2021-2026)
- 4.2.3 Global Colchicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Colchicine Forecasted Market Size by Region
- 4.3.1 Global Colchicine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Colchicine Sales in Value by Region (2027-2032)
- 4.3.3 Global Colchicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Colchicine by Application
- 5.1 Colchicine Market by Application
- 5.1.1 Acute Gout
- 5.1.2 Chronic Gout
- 5.1.3 Other Conditions
- 5.2 Global Colchicine Market Size by Application
- 5.2.1 Global Colchicine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Colchicine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Colchicine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Colchicine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Colchicine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Colchicine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Colchicine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Colchicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yunnan Plant Medicine
- 6.1.1 Yunnan Plant Medicine Company Information
- 6.1.2 Yunnan Plant Medicine Business Overview
- 6.1.3 Yunnan Plant Medicine Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yunnan Plant Medicine Colchicine Product Portfolio
- 6.1.5 Yunnan Plant Medicine Recent Developments
- 6.2 Xishuangbanna Pharmaceutical
- 6.2.1 Xishuangbanna Pharmaceutical Company Information
- 6.2.2 Xishuangbanna Pharmaceutical Business Overview
- 6.2.3 Xishuangbanna Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Xishuangbanna Pharmaceutical Colchicine Product Portfolio
- 6.2.5 Xishuangbanna Pharmaceutical Recent Developments
- 6.3 Takeda Pharmaceuticals
- 6.3.1 Takeda Pharmaceuticals Company Information
- 6.3.2 Takeda Pharmaceuticals Business Overview
- 6.3.3 Takeda Pharmaceuticals Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Takeda Pharmaceuticals Colchicine Product Portfolio
- 6.3.5 Takeda Pharmaceuticals Recent Developments
- 6.4 Tonghua Limin
- 6.4.1 Tonghua Limin Company Information
- 6.4.2 Tonghua Limin Business Overview
- 6.4.3 Tonghua Limin Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Tonghua Limin Colchicine Product Portfolio
- 6.4.5 Tonghua Limin Recent Developments
- 6.5 Kunming Pharmaceutical
- 6.5.1 Kunming Pharmaceutical Company Information
- 6.5.2 Kunming Pharmaceutical Business Overview
- 6.5.3 Kunming Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Kunming Pharmaceutical Colchicine Product Portfolio
- 6.5.5 Kunming Pharmaceutical Recent Developments
- 6.6 Beijing Jialin Pharmaceutical
- 6.6.1 Beijing Jialin Pharmaceutical Company Information
- 6.6.2 Beijing Jialin Pharmaceutical Business Overview
- 6.6.3 Beijing Jialin Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Beijing Jialin Pharmaceutical Colchicine Product Portfolio
- 6.6.5 Beijing Jialin Pharmaceutical Recent Developments
- 6.7 Yunnan Shan State
- 6.7.1 Yunnan Shan State Company Information
- 6.7.2 Yunnan Shan State Business Overview
- 6.7.3 Yunnan Shan State Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Yunnan Shan State Colchicine Product Portfolio
- 6.7.5 Yunnan Shan State Recent Developments
- 6.8 Wockhardt
- 6.8.1 Wockhardt Company Information
- 6.8.2 Wockhardt Business Overview
- 6.8.3 Wockhardt Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Wockhardt Colchicine Product Portfolio
- 6.8.5 Wockhardt Recent Developments
- 6.9 West-Ward
- 6.9.1 West-Ward Company Information
- 6.9.2 West-Ward Business Overview
- 6.9.3 West-Ward Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 West-Ward Colchicine Product Portfolio
- 6.9.5 West-Ward Recent Developments
- 6.10 Rhea Pharmaceutical
- 6.10.1 Rhea Pharmaceutical Company Information
- 6.10.2 Rhea Pharmaceutical Business Overview
- 6.10.3 Rhea Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Rhea Pharmaceutical Colchicine Product Portfolio
- 6.10.5 Rhea Pharmaceutical Recent Developments
- 6.11 Prasco
- 6.11.1 Prasco Company Information
- 6.11.2 Prasco Business Overview
- 6.11.3 Prasco Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Prasco Colchicine Product Portfolio
- 6.11.5 Prasco Recent Developments
- 6.12 Odan Laboratories
- 6.12.1 Odan Laboratories Company Information
- 6.12.2 Odan Laboratories Business Overview
- 6.12.3 Odan Laboratories Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Odan Laboratories Colchicine Product Portfolio
- 6.12.5 Odan Laboratories Recent Developments
- 6.13 Medinova
- 6.13.1 Medinova Company Information
- 6.13.2 Medinova Business Overview
- 6.13.3 Medinova Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Medinova Colchicine Product Portfolio
- 6.13.5 Medinova Recent Developments
- 6.14 Hikma
- 6.14.1 Hikma Company Information
- 6.14.2 Hikma Business Overview
- 6.14.3 Hikma Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Hikma Colchicine Product Portfolio
- 6.14.5 Hikma Recent Developments
- 6.15 Guangdong Pedi
- 6.15.1 Guangdong Pedi Company Information
- 6.15.2 Guangdong Pedi Business Overview
- 6.15.3 Guangdong Pedi Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Guangdong Pedi Colchicine Product Portfolio
- 6.15.5 Guangdong Pedi Recent Developments
- 6.16 Excellium Pharmaceutical
- 6.16.1 Excellium Pharmaceutical Company Information
- 6.16.2 Excellium Pharmaceutical Business Overview
- 6.16.3 Excellium Pharmaceutical Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Excellium Pharmaceutical Colchicine Product Portfolio
- 6.16.5 Excellium Pharmaceutical Recent Developments
- 6.17 Cipla
- 6.17.1 Cipla Company Information
- 6.17.2 Cipla Business Overview
- 6.17.3 Cipla Colchicine Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Cipla Colchicine Product Portfolio
- 6.17.5 Cipla Recent Developments
7 North America by Country
- 7.1 North America Colchicine Sales by Country
- 7.1.1 North America Colchicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Colchicine Sales by Country (2021-2026)
- 7.1.3 North America Colchicine Sales Forecast by Country (2027-2032)
- 7.2 North America Colchicine Market Size by Country
- 7.2.1 North America Colchicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Colchicine Market Size by Country (2021-2026)
- 7.2.3 North America Colchicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Colchicine Sales by Country
- 8.1.1 Europe Colchicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Colchicine Sales by Country (2021-2026)
- 8.1.3 Europe Colchicine Sales Forecast by Country (2027-2032)
- 8.2 Europe Colchicine Market Size by Country
- 8.2.1 Europe Colchicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Colchicine Market Size by Country (2021-2026)
- 8.2.3 Europe Colchicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Colchicine Sales by Country
- 9.1.1 Asia-Pacific Colchicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Colchicine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Colchicine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Colchicine Market Size by Country
- 9.2.1 Asia-Pacific Colchicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Colchicine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Colchicine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Colchicine Sales by Country
- 10.1.1 South America Colchicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Colchicine Sales by Country (2021-2026)
- 10.1.3 South America Colchicine Sales Forecast by Country (2027-2032)
- 10.2 South America Colchicine Market Size by Country
- 10.2.1 South America Colchicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Colchicine Market Size by Country (2021-2026)
- 10.2.3 South America Colchicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Colchicine Sales by Country
- 11.1.1 Middle East and Africa Colchicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Colchicine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Colchicine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Colchicine Market Size by Country
- 11.2.1 Middle East and Africa Colchicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Colchicine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Colchicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Colchicine Value Chain Analysis
- 12.1.1 Colchicine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Colchicine Production Mode & Process
- 12.2 Colchicine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Colchicine Distributors
- 12.2.3 Colchicine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst